ASA after Anticoagulation in Venous Thromboembolism
Aspirin reduces the risk of recurrence when given to patients with unprovoked VTE who had discontinued anticoagulant treatment, with no increase in major bleeding risk.
Peter C. Block, M.D., F.A.C.C.
Statements or opinions expressed in this program reflects the views of the contributors
and
do not reflect the official policy of the ACCF, unless otherwise noted.